Shares of Alembic Pharmaceuticals dipped 8 per cent to Rs 840 on the BSE in intra-day trade on Tuesday after the company reported disappointing numbers for the quarter ended June 2021 (Q1FY22), with consolidated profit after tax (PAT) declining 45.4 per…
Alembic Pharma dips 8% on disappointing June quarter results
Share this article
More News


Oneglobal completes takeover of Hong Kong crypto specialist Fraction
September 22, 2026



Robinhood stock hits 9-month high as crypto market rebounds
September 21, 2026

